NCT06965309 2026-02-12Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)Shenzhen MagicRNA Biotechnology Co., LtdPhase NA Terminated9 enrolled
NCT04226170 2025-09-11Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia GravisDAS-MG, IncPhase 2 Terminated2 enrolled